Bone Diseases, Metabolic

• Research Site — Busan, South Korea
• Research Site — Gwangju, South Korea
• Research Site — Namdong-gu, Incheon, South Korea
• Research Site — Seongnam Si Gyeonggi Do, South Korea

• For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. — Birmingham, Alabama, United States
• For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. — Concord, California, United States
• For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. — Fresno, California, United States
• For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. — Laguna Hills, California, United States

• Tameside Hospital NHS Foundation Trust — Ashton-under-Lyne, Greater Manchester, United Kingdom

• M D Anderson Cancer Center — Houston, Texas, United States

• Investigating site BE01 — Anderlecht, Belgium

• Duke Center for Metabolic and Weight Loss Surgery — Durham, North Carolina, United States

• Julio Iván Aguayo — Guadalajara, Jalisco, Mexico

Not specified

Not specified

• University of California, Los Angeles — Los Angeles, California, United States